BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 25773480)

  • 1. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose.
    Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC
    Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of CYP2D6 polymorphisms on the pharmacokinetics of codeine and its metabolites in Mongolian Chinese subjects.
    Wu X; Yuan L; Zuo J; Lv J; Guo T
    Eur J Clin Pharmacol; 2014 Jan; 70(1):57-63. PubMed ID: 24077935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.
    Bouwmeester NJ; Anderson BJ; Tibboel D; Holford NH
    Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
    Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
    Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
    Du X; Skopp G; Aderjan R
    Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration--a dose escalation study.
    Brokjær A; Kreilgaard M; Olesen AE; Simonsson US; Christrup LL; Dahan A; Drewes AM
    Eur J Pharm Sci; 2015 Feb; 68():78-86. PubMed ID: 25486331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
    Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
    Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
    Quigley C; Joel S; Patel N; Baksh A; Slevin M
    Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
    Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
    Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain.
    Hunt A; Joel S; Dick G; Goldman A
    J Pediatr; 1999 Jul; 135(1):47-55. PubMed ID: 10393603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codeine in post-operative pain. Study of the influence of sparteine phenotype and serum concentrations of morphine and morphine-6-glucuronide.
    Poulsen L; Riishede L; Brøsen K; Clemensen S; Sindrup SH
    Eur J Clin Pharmacol; 1998 Aug; 54(6):451-4. PubMed ID: 9776433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.
    Klepstad P; Dale O; Kaasa S; Zahlsen K; Aamo T; Fayers P; Borchgrevink PC
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):725-31. PubMed ID: 12803591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers.
    Lötsch J; Skarke C; Schmidt H; Liefhold J; Geisslinger G
    Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-mortem levels and tissue distribution of codeine, codeine-6-glucuronide, norcodeine, morphine and morphine glucuronides in a series of codeine-related deaths.
    Frost J; Løkken TN; Helland A; Nordrum IS; Slørdal L
    Forensic Sci Int; 2016 May; 262():128-37. PubMed ID: 26986973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease.
    Molanaei H; Carrero JJ; Heimbürger O; Nordfors L; Lindholm B; Stenvinkel P; Odar-Cederlöf I; Bertilsson L
    Eur J Clin Pharmacol; 2010 Mar; 66(3):269-73. PubMed ID: 19940985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral morphine dosing predictions based on single dose in healthy children undergoing surgery.
    Dawes JM; Cooke EM; Hannam JA; Brand KA; Winton P; Jimenez-Mendez R; Aleksa K; Lauder GR; Carleton BC; Koren G; Rieder MJ; Anderson BJ; Montgomery CJ
    Paediatr Anaesth; 2017 Jan; 27(1):28-36. PubMed ID: 27779356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants.
    Bouwmeester NJ; van den Anker JN; Hop WC; Anand KJ; Tibboel D
    Br J Anaesth; 2003 May; 90(5):642-52. PubMed ID: 12697593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
    De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M
    Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
    Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
    Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 phenotype-specific codeine population pharmacokinetics.
    Linares OA; Fudin J; Schiesser WE; Daly Linares AL; Boston RC
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):4-15. PubMed ID: 25562725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.